| Trial ID: | L0264 |
| Source ID: | NCT00443079
|
| Associated Drug: |
IdB 1016
|
| Title: |
A Study of Siliphos in Adults With Non-alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
Has Results
|
| Results: |
https://ClinicalTrials.gov/show/NCT00443079/results
|
| Conditions: |
Fatty Liver
|
| Interventions: |
Drug: IdB 1016 (Siliphos)|Drug: Matched placebo
|
| Outcome Measures: |
Number of Study Participants With Adverse Events|Number of Participants With a Decrease in ALT Value Greater Than or Equal to 15 U/L From Baseline to the End of the Treatment Era
|
| Sponsor/Collaborators: |
Heather Patton|American College of Gastroenterology|University of California, San Diego
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
6
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Non-Randomized|Intervention Model: Crossover Assignment|Masking: Single (Participant)|Primary Purpose: Treatment
|
| Start Date: |
March 2007
|
| Completion Date: |
December 2009
|
| Results First Posted: |
March 24, 2021
|
| Last Update Posted: |
March 24, 2021
|
| Locations: |
University of California, San Diego Medical Center, San Diego, California, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00443079
|
